市場調査レポート
商品コード
1410834
ヒトTリンパ向性ウイルス市場:市場規模(セグメント別)、シェア、規制、償還、予測(~2033年)Human T-Lymphotropic Virus Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ヒトTリンパ向性ウイルス市場:市場規模(セグメント別)、シェア、規制、償還、予測(~2033年) |
出版日: 2023年11月29日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
ヒトTリンパ向性ウイルス(HTLV)はTリンパ球細胞に感染するレトロウイルスです。HTLVには4つの株があり、このうちHTLV-IとHTLV-IIが最も流行しています。HTLV検査はATLL診断の一環として、リンパ腫やT細胞障害の患者にしばしば実施されます。HTLV検査は人工授精や献血者にも行われます。
ヒトTリンパ向性ウイルス(HTLV)検査には、HTLV酵素免疫アッセイ/酵素結合免疫吸着アッセイ(EIA/ELISA)検査とその他のHTLV検査が含まれます。
当レポートは、世界のヒトTリンパ向性ウイルス市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Human T-Lymphotropic Virus Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on HTLV tests market for the year 2020 and beyond. HTLV is a retrovirus that infects T Lymphocyte cells. There are four strains of HTLV, out of these HTLV-I and HTLV-II are the most prevalent. HTLV testing is often performed in patients with lymphomas or T cell disorders as part of ATLL diagnosis. HTLV tests are performed in Artificial Insemination, and blood donors.
Human T-Lymphotropic Virus (HTLV) Tests includes HTLV Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests and Other HTLV Tests.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Human T-Lymphotropic Virus (HTLV) tests and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: F. Hoffmann-La Roche Ltd, Abbott Laboratories, DiaSorin SpA, H.U. Group Holdings Inc, Werfen Life SA, MP Biomedicals LLC and others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable